(Q46986240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Thijs J Giezen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Aukje K Mantel-Teeuwisse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sabine M J M Straus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Stella Blackburn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ingemar Persson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hubert G M Leufkens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1175-1187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11318980-000000000-00000

12 February 2020

exact match

0 references

cites work

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

12 December 2020

Immunogenicity of biopharmaceuticals

1 reference

12 December 2020

Pharmacovigilance in perspective

1 reference

12 December 2020

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

1 reference

12 December 2020

Under-reporting of adverse drug reactions : a systematic review

1 reference

12 December 2020

Immunogenicity of rDNA-derived pharmaceuticals

1 reference

12 December 2020

Pharmacovigilance of biopharmaceuticals: challenges remain

1 reference

12 December 2020

Detection, verification, and quantification of adverse drug reactions

1 reference

12 December 2020

1 reference

12 December 2020

Follow-on biologics: challenges of the "next generation".

1 reference

12 December 2020

Predictors of orphan drug approval in the European Union

1 reference

12 December 2020

Immunologic mechanisms of EPO-associated pure red cell aplasia

1 reference

12 December 2020

Developments in post-marketing comparative effectiveness research

1 reference

12 December 2020

Shifting paradigms: biopharmaceuticals versus low molecular weight drugs

1 reference

12 December 2020

Long-term risks associated with biologic response modifiers used in rheumatic diseases.

1 reference

12 December 2020

'Biogenerics': the off-patent biotech products

1 reference

12 December 2020

Guidelines for good pharmacoepidemiology practices (GPP).

1 reference

12 December 2020

10.2165/11318980-000000000-00000

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19916584%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 February 2020

1040391736

0 references

1 reference